al (2017) showed that BCAT1 is upregulated in and important for disease progression from chronic myeloid leukemia (CML) chronic phase to blast crisis, and that it is also important in de novo AML. The gene discussed is BCAT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.